Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
3uDyS3YQXZ2MsMQa
Listen
